Janus Henderson Group
GSK icon

Janus Henderson Group’s GSK GSK Stock Holding History

Janus Henderson Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-7,671
Closed -$366K – 2563
2021
Q3 		$366K Buy
+7,671
New +$385K ﹤0.01% 1783
2021
Q2 		– Sell
-6,938
Closed -$310K – 1632
2021
Q1 		$310K Buy
6,938
+679
+11% +$30.8K ﹤0.01% 1408
2020
Q4 		$288K Buy
+6,259
New +$288K ﹤0.01% 1328

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Janus Henderson Group's GSK Position: Q4 2021 in Review

Janus Henderson Group sold out of GSK (GSK) in Q4 2021, closing a stake of 7,671 shares — an estimated $366K sold.

Janus Henderson Group first reported a position in GSK in Q4 2020 and held it in 3 quarters. The position peaked at $366K in Q3 2021. 919 funds tracked by Wall St. Rank hold GSK as of Q4 2021.

  • Janus Henderson Group reported no remaining GSK position as of Q4 2021 after selling out during the quarter.
  • Janus Henderson Group sold 7,671 GSK shares in Q4 2021, an estimated $366K.
  • Janus Henderson Group first reported a position in GSK in Q4 2020 and held it in 3 quarters.
  • Janus Henderson Group's GSK position peaked at $366K in Q3 2021.
  • 919 funds tracked by Wall St. Rank held GSK as of Q4 2021.

Based on Janus Henderson Group's 13F filing for Q4 2021, filed 14 Feb 2022.